Piper Sandler on GeneDx (WGS): 'Aggressively buy on any reset sell-off'
Piper Sandler analyst David Westenberg reiterated an Overweight rating and $130.00 price target on GeneDx (NASDAQ: WGS).The analyst commented: "Sequencing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)